Publications by authors named "Daniel Vittecoq"

Claim this Profile
S
Severe Scabies: A French Multi-centre Study Involving 95 Patients with Crusted and Profuse Disease and Review of the Literature.
Charbel Skayem, Majda Askour, Charlotte Gary, Francois Hemery, Emmanuel Mahé, Daniel Vittecoq

Acta Derm Venereol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding the spectrum of HIV-associated myopathy.
Océane Landon-Cardinal, Laure Gallay, Odile Dubourg, Thierry Maisonobe, Sarah Léonard-Louis, Daniel Vittecoq

J Neurol Neurosurg Psychiatry· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.
Mathieu Chalouni, Philippe Sogni, Patrick Miailhes, Karine Lacombe, Isabelle Poizot-Martin, Daniel Vittecoq

Eur J Gastroenterol Hepatol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.
Sarah Shili-Masmoudi, Philippe Sogni, Victor de Ledinghen, Laure Esterle, Marc-Antoine Valantin, Daniel Vittecoq

PLoS One· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort.
Oumar Billa, Mathieu Chalouni, Dominique Salmon, Isabelle Poizot-Martin, Camille Gilbert, Daniel Vittecoq

PLoS One· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort.
Lionel Piroth, Linda Wittkop, Karine Lacombe, Eric Rosenthal, Camille Gilbert, Daniel Vittecoq

J Hepatol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).
Fabienne Marcellin, Camelia Protopopescu, Laure Esterle, Linda Wittkop, Lionel Piroth, Daniel Vittecoq

Eur J Gastroenterol Hepatol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Occurrence of OXA-72-Producing Acinetobacter baumannii in Serbia.
Laurent Dortet, Rémy A Bonnin, Sandrine Bernabeu, Lélia Escaut, Daniel Vittecoq

Antimicrob Agents Chemother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intention to vaccinate against influenza among health care workers caring for immunocompromised patients.
Pierre Loulergue, Solen Kernéis, Jean-Baptiste Stern, Najiby Kassis-Chikani, Ouda Derradji, Daniel Vittecoq

Am J Infect Control· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort.
Philippe Sogni, Camille Gilbert, Karine Lacombe, Lionel Piroth, Eric Rosenthal, Daniel Vittecoq

Clin Infect Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atteinte oculaire de la rougeole chez un adulte non vacciné.
Antoine Rousseau, Mohammed M'Garrech, Stanislas Rebaudet, Daniel Vittecoq, Marc Labetoulle

Virologie (Montrouge)· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.
Etienne Ruppé, Laurence Armand-Lefèvre, Candice Estellat, Paul-Henri Consigny, Assiya El Mniai, Daniel Vittecoq

Clin Infect Dis· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
David Saadoun, Matthieu Resche Rigon, Stanislas Pol, Vincent Thibault, François Blanc, Daniel Vittecoq

J Hepatol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.
Teresa Maria Antonini, Valerie Furlan, Elina Teicher, Stephanie Haim-Boukobza, Mylene Sebagh, Daniel Vittecoq

AIDS· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photo quiz. Dyspnea and fever in an allogeneic stem cell recipient.
Adela Angoulvant, Jean-Baptiste Stern, Sebastian Wittnebel, Jean-Henri Bourhis, Bertrand Gachot, Daniel Vittecoq

Clin Infect Dis· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.
Laurent Cotte, Joséphine Braun, Caroline Lascoux-Combe, Corine Vincent, Marc-Antoine Valantin, Daniel Vittecoq

Clin Infect Dis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study.
Caroline Barau, Joséphine Braun, Corine Vincent, Stéphanie Haim-Boukobza, Jean-Michel Molina, Daniel Vittecoq

Clin Infect Dis· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Care of hepatitis C virus infection in France: modifications in three consecutive surveys between 1995 and 2010.
Guillaume Geri, Marianne Maynard, Eric Rosenthal, Hélène Fontaine, Karine Lacombe, Daniel Vittecoq

Liver Int· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts.
Evguenia Krastinova, Remonie Seng, Patrick Yeni, Jean-Paul Viard, Daniel Vittecoq

PLoS One· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft.
Teresa M Antonini, Valerie Furlan, Elina Teicher, Stephanie Haim-Boukobza, Mylene Sebagh, Daniel Vittecoq

AIDS· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eradication of an outbreak of vancomycin-resistant Enterococcus (VRE): the cost of a failure in the systematic screening.
Lélia Escaut, Samir Bouam, Marie Frank-Soltysiak, Eric Rudant, Faouzi Saliba, Daniel Vittecoq

Antimicrob Resist Infect Control· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort.
Marc-Arthur Loko, Firouze Bani-Sadr, Marc-Antoine Valantin, Caroline Lascoux-Combe, Hélène Fontaine, Daniel Vittecoq

Antivir Ther· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.
Dominique Salmon, Firouzé Bani-Sadr, Marc-Arthur Loko, Hind Stitou, Anne Gervais, Daniel Vittecoq

J Hepatol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial.
Catherine Fagard, Céline Colin, Charlotte Charpentier, Agathe Rami, Christine Jacomet, Daniel Vittecoq

J Acquir Immune Defic Syndr· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Infections at risk for epidemic or biological threat. Importance of the initial management of suspect patients].
Catherine Leport, Daniel Vittecoq, Christian Perronne, Thierry Debord, Pierre Carli

Presse Med· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis